TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value ($000): $836,969 (100.0% shares, 0.0% debt)

Holdings (17)

— ODONATE THERAPEUTICS INC 54.6%

Value ($000) $456,742 Shares 14,075,269 Est. Cost $25.08 Unrealized —

HRTX HERON THERAPEUTICS INC 14.1%

Value ($000) $117,904 Shares 5,017,203 Est. Cost $14.10 Unrealized +56.9%

RCKT ROCKET PHARMACEUTICALS INC 8.1%

Value ($000) $67,494 Shares 2,965,485 Est. Cost $16.31 Unrealized +2.4%

RLMD RELMADA THERAPEUTICS INC 6.1%

Value ($000) $50,700 Shares 1,300,000 Est. Cost $28.22 Unrealized 0.0%

EOLS EVOLUS INC 3.8%

Value ($000) $32,068 Shares 2,635,000 Est. Cost $14.10 Unrealized 0.0%

ANAB ANAPTYSBIO INC 3.6%

Value ($000) $29,962 Shares 1,843,814 Est. Cost $23.65 Unrealized 0.0%

— AVROBIO INC 2.4%

Value ($000) $20,130 Shares 1,000,000 Est. Cost $15.15 Unrealized —

— LA JOLLA PHARMACEUTICAL CO 2.3%

Value ($000) $19,410 Shares 4,938,893 Est. Cost $15.94 Unrealized —

REGN REGENERON PHARMACEUTICALS 2.0%

Value ($000) $16,897 Shares 45,000 Est. Cost $334.59 Unrealized 0.0%

BMY BRISTOL MYERS SQUIBB CO 0.9%

Value ($000) $7,179 Shares 111,844 Est. Cost $45.19 Unrealized 0.0%

PRTA PROTHENA CORP PLC 0.8%

Value ($000) $6,709 Shares 423,823 Est. Cost $11.57 Unrealized -7.3%

— G1 THERAPEUTICS INC 0.5%

Value ($000) $4,493 Shares 170,000 Est. Cost $30.16 Unrealized —

PBYI PUMA BIOTECHNOLOGY INC 0.4%

Value ($000) $3,057 Shares 349,400 Est. Cost $30.17 Unrealized -72.6%

— IVERIC BIO INC 0.3%

Value ($000) $2,145 Shares 250,000 Est. Cost $1.30 Unrealized —

— NUCANA PLC 0.2%

Value ($000) $1,525 Shares 250,000 Est. Cost $7.24 Unrealized —

— BRISTOL MYERS SQUIBB CO 0.0%

Value ($000) $337 Shares 111,844 Est. Cost $3.01 Unrealized —

— EIDOS THERAPEUTICS INC 0.0%

Value ($000) $217 Shares 3,783 Est. Cost $57.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ODONATE THERAPEUTICS INC	14,075,269	$456,742	54.6%	$25.08	—	COM	676079106
HRTX	HERON THERAPEUTICS INC	5,017,203	$117,904	14.1%	$14.10	+56.9%	COM	427746102
RCKT	ROCKET PHARMACEUTICALS INC	2,965,485	$67,494	8.1%	$16.31	+2.4%	COM	77313F106
RLMD	RELMADA THERAPEUTICS INC	1,300,000	$50,700	6.1%	$28.22	0.0%	COM	75955J402
EOLS	EVOLUS INC	2,635,000	$32,068	3.8%	$14.10	0.0%	COM	30052C107
ANAB	ANAPTYSBIO INC	1,843,814	$29,962	3.6%	$23.65	0.0%	COM	032724106
—	AVROBIO INC	1,000,000	$20,130	2.4%	$15.15	—	COM	05455M100
—	LA JOLLA PHARMACEUTICAL CO	4,938,893	$19,410	2.3%	$15.94	—	COM	503459604
REGN	REGENERON PHARMACEUTICALS	45,000	$16,897	2.0%	$334.59	0.0%	COM	75886F107
BMY	BRISTOL MYERS SQUIBB CO	111,844	$7,179	0.9%	$45.19	0.0%	COM	110122108
PRTA	PROTHENA CORP PLC	423,823	$6,709	0.8%	$11.57	-7.3%	SHS	G72800108
—	G1 THERAPEUTICS INC	170,000	$4,493	0.5%	$30.16	—	COM	3621LQ109
PBYI	PUMA BIOTECHNOLOGY INC	349,400	$3,057	0.4%	$30.17	-72.6%	COM	74587V107
—	IVERIC BIO INC	250,000	$2,145	0.3%	$1.30	—	COM	46583P102
—	NUCANA PLC	250,000	$1,525	0.2%	$7.24	—	SPONSORED ADR	67022C106
—	BRISTOL MYERS SQUIBB CO	111,844	$337	0.0%	$3.01	—	RIGHT 99/99/9999	110122157
—	EIDOS THERAPEUTICS INC	3,783	$217	0.0%	$57.36	—	COM	28249H104